Literature DB >> 24206838

Middle East respiratory syndrome coronavirus in bats, Saudi Arabia.

Ziad A Memish, Nischay Mishra, Kevin J Olival, Shamsudeen F Fagbo, Vishal Kapoor, Jonathan H Epstein, Rafat Alhakeem, Abdulkareem Durosinloun, Mushabab Al Asmari, Ariful Islam, Amit Kapoor, Thomas Briese, Peter Daszak, Abdullah A Al Rabeeah, W Ian Lipkin.   

Abstract

The source of human infection with Middle East respiratory syndrome coronavirus remains unknown. Molecular investigation indicated that bats in Saudi Arabia are infected with several alphacoronaviruses and betacoronaviruses. Virus from 1 bat showed 100% nucleotide identity to virus from the human index case-patient. Bats might play a role in human infection.

Entities:  

Keywords:  MERS CoV; Middle East respiratory syndrome; Saudi Arabia; bats; coronavirus; viruses

Mesh:

Year:  2013        PMID: 24206838      PMCID: PMC3837665          DOI: 10.3201/eid1911.131172

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Since Middle East respiratory syndrome (MERS) was described in September 2012, over 90 cases have been reported worldwide, 70 from Saudi Arabia. The incidence of infection with the causative agent, a betacoronavirus (MERS CoV) (), has not been determined; however, the mortality rate among those who received clinical care is ≈65% (). Although instances of human-to-human transmission have been documented between case-patients and others in close contact (including hospital patients sharing rooms, family members, and medical personnel), the sources of infection for most patients remain unknown. Because of sequence similarities between β-CoVs identified in bats and those of MERS CoV isolated from humans, a bat reservoir has been posited (–). Although neither detection of MERS CoV in bats nor contact of human MERS patients with bats have been reported, a role for bats in human infection cannot be excluded because contact can be indirect (mediated through another animal vector or fomites).

The Study

In October 2012 and April 2013, three agencies collected samples from bats in regions where MERS cases had been identified (Figure 1). The agencies are the Ministry of Health of Saudi Arabia, the Center for Infection and Immunity of Columbia University, and EcoHealth Alliance.
Figure 1

Bat sampling sites and locations of home and workplace of index case-patient with Middle East respiratory syndrome, Bisha, Saudi Arabia.

Bat sampling sites and locations of home and workplace of index case-patient with Middle East respiratory syndrome, Bisha, Saudi Arabia. During the October investigation, the team interviewed the family of an index case-patient in Bisha and collected samples from bats <12 km from his home, in an abandoned date palm orchard, and <1 km from his place of employment, a hardware store that fronted a garden and date palm orchard. Although neither family members nor employees recalled seeing bats, the team observed roosting bats and guano in abandoned wells and ruins within 12 km of his home and insectivorous bats at dusk in the garden behind his store. Over 3 weeks, 96 bats representing 7 species (Rhinopoma hardwickii, Rhinopoma microphyllum, Taphozous perforatus, Pipistrellus kuhlii, Eptesicus bottae, Eidolon helvum, and Rosettus aegyptiacus) were captured in mist nets and harp traps, then released after visual speciation and collection of morphometric measurements; wing punch biopsy samples; blood; throat swab samples; and rectal swab samples or fecal pellets. Samples were collected into viral transport medium or lysis buffer. During the 3-week April investigation, fecal samples were collected on tarps laid out at bat roosting sites in and around Bisha, Unaizah, and Riyadh. Representative animals at each roosting site were captured, identified morphologically, and released after wing punch biopsy samples were collected for speciation by DNA analysis. Samples were collected into cryovials. All samples were stored in liquid nitrogen and conveyed to Riyadh for storage at −80°C before being transported to Columbia University in New York in dry nitrogen. The October 2012 shipment was inadvertently opened at customs in the United States and sat at room temperature for 48 hours before transfer to Columbia University; at arrival, all samples had thawed. The April 2013 samples arrived intact. Total nucleic acid was extracted from samples by using the NucliSENS easyMAG system (bioMérieux, Durham, NC, USA) and subjected to 8 PCRs with primers and protocols designed to amplify regions within the helicase, RNA-dependent RNA polymerase (RdRp), and nucleocapsid or envelope proteins of CoVs (–). Products were sequenced and analyzed for similarity to GenBank database entries by using the BLASTn and BLASTx programs (www.ncbi.nlm.nih.gov/blast/Blast.cgi). Primer sequences are shown in Table 1. The identity of bat species yielding specific viral products was determined by amplifying and sequencing a fragment of the cytochrome B gene (). All visual classifications of species were confirmed except for that of T. perforatus bats. There is no reference sequence for T. perforatus bats in GenBank. However, because the closest reference sequence was from T. nudiventris bats, at 84% identity we presume that the product represents bona fide T. perforatus bat cytochrome B gene sequence. Representative cytochrome B sequences have been uploaded to GenBank (accession nos. KF498635–KF498641).
Table 1

PCRs and primers used in CoV detection*

PCRs (reference)Primers, 5′→3′Nested fragment size, region (primer locations on the reference) genome)†Type of CoV (no.)
Nested pan-CoV-I (6)PLQ-F1, CGTTGGIACWAAYBTVCCWYTICARBTRGG≈400 nt, RdRp (18310–187450)α-CoV (8), β-CoV (1)
PLQ-R1, GGTCATKATAGCRTCAVMASWWGCNACATG
PLQ-F2, GGCWCCWCCHGGNGARCAATT
PLQ-R2, GGWAWCCCCAYTGYTGWAYRTC
Nested pan-CoV-II (7)WT-COV-F1, GGTTGGGAYTAYCCHAARTGTGA≈430 nt, RdRp (15260–15700)α-CoV (5), β-CoV (2)
WT-COV-R1, CCATCATCASWYRAATCATCATA
WT-COV-F2, GAYTAYCCHAARTGTGAYAGAGC
WT-COV-F3, GAYTAYCCHAARTGTGAUMGWGC
Hemi-nested RdRp-sequence assay (9)EMC-SeqRdRP-Rev, GCATWGCNCWGTCACACTTAGG ≈230 nt, RdRp (15048–15290)α-CoV (2), β-CoV (1)
EMC-SeqRdRP-Fwd, TGCTATWAGTGCTAAGAATAGRGC
EMC-SeqRdRP-Rnest, CACTTAGGRTARTCCCAWCCCA
Hemi-nested N-sequence assay (9)EMC-SeqN-Fwd, CCTTCGGTACAGTGGAGCCA ≈280 nt,N seq (29,549–29,860)
EMC-SeqN-Rev, GATGGGGTTGCCAAACACAAAC
EMC-SeqN-Fnest, TGACCCAAAGAATCCCAACTAC
Nested CII-pan-CoV-IIINM-CoV-2F1, ACWGTTCARGGICCWCCIGG≈355 nt, helicase (17,060–17,410)β-CoV (2)
NM-CoV-2F2, GTTCARGGGCCWCCGGGNAC
NM-CoV-2R1, GGCAGCTGWGCWGGRTCICCNACRTA
NM-CoV-2R2, AGCTGWGCWGGRTCGCCIACRTANAC
Nested CII-MERS-RdRpNM-HCOV-F1, GTGCTAAGAATAGAGCTCGCACT
NM-HCOV-F2, AGAGCTCGCACTGTTGCAGGC≈190 nt, RdRp (15068–15249)β-CoV (1, MERS CoV)
NM-HCOV-F2, AGAGCTCGCACTGTTGCAGGC
NM-HCOV-R1, ACCCATAAGATGCGGATTATCAAC
NM-HCOV-R2, TGCGGATTATCAACATCTTTGTAC
Hemi-nested CII-MERS N sequenceNM-NSeq-F-1, ACTTCCTTCGGTACAGTGGAGC≈170 nt, N seq (29545–29713)
NM-NSeq-R-1, GGCACTGTTCACTTGCAATC
NM-NSeq-R-2, GGAGGTTCAGACATTTGGTCT
upE and ORF1b real-time assays (8)upE-Fwd: GCAACGCGCGATTCAGTT Upstream of E gene and ORF 1b
upE-Prb: FAM-CTCTTCACATAATCGCCCCGAGCTCG-TAMRA
upE-Rev: GCCTCTACACGGGACCCATA
ORF1b-Fwd: TTCGATGTTGAGGGTGCTCAT
ORF1b-Prb: FAM-CCCGTAATGCATGTGGCACCAATGT-TAMRA
ORF1b-Rev: TCACACCAGTTGAAAATCCTAATTG

* CoV, coronavirus; MERS, Middle East respiratory syndrome; RdRp, RNA-dependent RNA polymerase; –, not applicable; ORF, open reading frame.
†Primer locations are based on human β-CoV 2c EMC/2012, complete genome (GenBank accession no. JX869059).

* CoV, coronavirus; MERS, Middle East respiratory syndrome; RdRp, RNA-dependent RNA polymerase; –, not applicable; ORF, open reading frame.
†Primer locations are based on human β-CoV 2c EMC/2012, complete genome (GenBank accession no. JX869059). Table 1 indicates the CoV genera identified by using individual primer sets. As anticipated, pan-CoV assays detected α- and β-CoVs. One assay specific for MERS CoV () also detected α-CoVs. This finding reinforces the need for sequence confirmation of PCR products. Table 2 indicates the CoV species identified with respect to location, sample type, and bat species. CoV sequences were amplified from rectal swab samples or fecal pellets and from roost feces but not from serum, throat swab samples, or urine. Alpha CoV sequences were amplified more frequently than β-CoV sequences (223 vs 4). Whereas α- and β-CoV sequences were amplified from CoVs from T. perforatus, E. helvum, and R. hardwickii bats, only alpha sequences were amplified from CoVs from P. kuhlii bat samples.
Table 2

CoVs detected in bats, Saudi Arabia*

Bat family, genus, species
Location
No. Bats
No. samples tested (no. positive)
Total samples (n = 1,003)
Total positive samples (n = 227) (closely related CoVs)†
Throat swab
Fecal pellets
Urine
Serum
Roost feces
October 2012









Emballonuridae
Taphozous perforatus Bisha ruins2929 (0)25 (2)8 (0)2210 (1)941 β-Cov
(1 MERS novel CoV) and 2 α-CoVs
(1 bovine respiratory CoV, 1 Kenya bat CoV BtKY86)
Pteropodidae
Eidolon helvum Bisha town center2525 (0)25 (5)13 (0)19821 β-CoV (1 Eidolon bat CoV-HKU1) and 
4 α-CoVs (4 Kenya bat CoV BtKY86)
Rousettus aegyptiacus Bisha town center33 (0)3 (0)1 (0)29
Rhinopomatidae
Rhinopoma hardwickii Naqi and Old Naqi3636 (0)35 (0)4 (0)15 (0)90
Rhinopoma microphyllum Old Naqi11 (0)1 (0)2
Vespertilionidae
Eptesicus bottae Bisha ruins11 (0)1 (0)1 (0)32 (0)35
Pipistrellus kuhlii
Bisha ruins
1
1 (0)
1 (0)



2

April 2013









Rhinopomatidae
Rhinopoma hardwickii Greater Bisha area209 (93)2092 β-CoVs (2 canine respiratory CoVs) and
91α-CoVs (5 canine CoVs, 2 Miniopterus bat CoVs, 84 Chaerephon bat CoV)
Taphozous perforatus Bisha ruins203 (0)203
Vespertilionidae
Pipistrellus kuhlii Greater Unaizah area99 (0)–-263 (126)277126 α-CoVs
(69 alphaCoV P.kuh-Spain,
3 canine CoVs,
37 bat CoV P.pyg/Germany,
1 human CoV NL63,
2 Rousettus bat CoV HKU10,
11 Porcine epidemic diarrhea virus,
2 Cardioderma bat CoVs,
1 Hipposideros bat CoV HKU10)
Greater Riyadh area55 (0)

*CoV, coronavirus; MERS, Middle East respiratory syndrome; –, not applicable. 
†Based on BLASTn (www.ncbi.nlm.nih.gov/blast/Blast.cgi).

*CoV, coronavirus; MERS, Middle East respiratory syndrome; –, not applicable. 
†Based on BLASTn (www.ncbi.nlm.nih.gov/blast/Blast.cgi). CoV sequences were amplified from 220 of 732 roost feces samples and 7 of 91 rectal swab samples or fecal pellets. A product obtained by PCR amplification of nucleic acid from a fecal pellet of a T. perforatus bat captured in October 2012 in Bisha showed 100% nt identity to the human β-CoV 2c EMC/2012 cloned from the index case-patient in Bisha. A phylogenetic analysis of CoVs obtained in this study is shown in Figure 2. CoV sequences have been uploaded in GenBank (accession nos. KF493884–KF493888).
Figure 2

Phylogenetic tree showing genetic relatedness between coronaviruses identified in bat samples from Saudi Arabia (boldface), MERS coronaviruses, and other published coronavirus sequences available in GenBank. The maximum-likelihood tree of partial RNA-dependent RNA polymerase gene (nt position 15068–15249 of GenBank accession no. JX869059) was constructed by using the Tamura-Nei model with discrete gamma rate differences among sites as implemented in MEGA 5.2 (www.megasoftware.net). Each branch shows the GenBank accession number followed by a brief description of the sequence used. Scale bar indicates nucleotide substitutions per site. MERS, Middle East respiratory syndrome; CoV, coronavirus; SARS, severe acute respiratory syndrome; KSA, Kingdom of Saudi Arabia.

Phylogenetic tree showing genetic relatedness between coronaviruses identified in bat samples from Saudi Arabia (boldface), MERS coronaviruses, and other published coronavirus sequences available in GenBank. The maximum-likelihood tree of partial RNA-dependent RNA polymerase gene (nt position 15068–15249 of GenBank accession no. JX869059) was constructed by using the Tamura-Nei model with discrete gamma rate differences among sites as implemented in MEGA 5.2 (www.megasoftware.net). Each branch shows the GenBank accession number followed by a brief description of the sequence used. Scale bar indicates nucleotide substitutions per site. MERS, Middle East respiratory syndrome; CoV, coronavirus; SARS, severe acute respiratory syndrome; KSA, Kingdom of Saudi Arabia.

Conclusions

A wide range of CoV species are circulating among bats in Saudi Arabia. Although the prevalence of CoVs was high (≈28% of fecal samples), MERS CoV was found in only 1 bat. A 3.5% MERS CoV infection rate (n = 29; 95% CI 0–20%) in T. perforatus bats is low compared with that for severe acute respiratory syndrome–like CoV in rhinolophid bats in China (10%–12.5%) but consistent with CoV prevalence among bats in Mexico (). Furthermore, the sensitivity for viral nucleic acid detection in samples collected in October 2012 was probably reduced because of failure in cold chain transport. Whereas 219 (32%) of 675 of fecal pellets collected in April revealed a CoV sequence by PCR, only 8 (5%) of 148 of rectal swab samples or fecal pellets collected in October were positive by the same assays. We were unable to recover additional sequences beyond the 190-nt RdRp fragment represented in Figure 2 but are confident in the fidelity of the finding. First, although RdRp is a conserved portion of the CoV genome, there is no precedent for 100% identity of a bat sequence with a human MERS CoV sequence. Second, when this work began we did not have cultured MERS CoV, human MERS samples, or MERS CoV cDNA in the laboratory at Columbia University where samples were removed directly from the tubes in which they were collected in the field for nucleic acid extraction, PCR, and sequence analysis. Third, the only MERS-positive signal was obtained in PCR analysis of the T. perforatus bat captured in Bisha near the home and workplace of the MERS index case-patient used to generate the human β-CoV 2c EMC/2012 sequence. Bats are reservoirs of several viruses that can cause human disease, including rabies, Hendra, Nipah, Marburg, severe acute respiratory syndrome CoV, and probably Ebola viruses (–). Cross-species transmission from bats to humans can be direct, through contact with infected bats or their excreta, or facilitated by intermediate hosts (). Bat CoVs are typically host specific; however, MERS-related CoVs have reportedly been found in many bat families, including Vespertillionidae, Molosidae, Nyteridae, and now Emballonuridae (sheath-tailed bats) in Africa, the Americas, Asia, and Europe. We sampled only a small sample of bats in Saudi Arabia. Nonetheless, given the rarity of MERS CoV sequences detected by our survey and the broad distribution of MERS cases throughout the Middle East, we speculate that there are probably other hosts. Future work should investigate additional bat and other wildlife species and domestic animals for CoV infection and potential linkage to human disease.
  15 in total

1.  Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections.

Authors:  V M Corman; M A Müller; U Costabel; J Timm; T Binger; B Meyer; P Kreher; E Lattwein; M Eschbach-Bludau; A Nitsche; T Bleicker; O Landt; B Schweiger; J F Drexler; A D Osterhaus; B L Haagmans; U Dittmer; F Bonin; T Wolff; C Drosten
Journal:  Euro Surveill       Date:  2012-12-06

2.  Identification of a novel coronavirus in bats.

Authors:  L L M Poon; D K W Chu; K H Chan; O K Wong; T M Ellis; Y H C Leung; S K P Lau; P C Y Woo; K Y Suen; K Y Yuen; Y Guan; J S M Peiris
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

3.  Bats are natural reservoirs of SARS-like coronaviruses.

Authors:  Wendong Li; Zhengli Shi; Meng Yu; Wuze Ren; Craig Smith; Jonathan H Epstein; Hanzhong Wang; Gary Crameri; Zhihong Hu; Huajun Zhang; Jianhong Zhang; Jennifer McEachern; Hume Field; Peter Daszak; Bryan T Eaton; Shuyi Zhang; Lin-Fa Wang
Journal:  Science       Date:  2005-09-29       Impact factor: 47.728

4.  Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats.

Authors:  Susanna K P Lau; Patrick C Y Woo; Kenneth S M Li; Yi Huang; Hoi-Wah Tsoi; Beatrice H L Wong; Samson S Y Wong; Suet-Yi Leung; Kwok-Hung Chan; Kwok-Yung Yuen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-16       Impact factor: 11.205

5.  Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia.

Authors:  Ali M Zaki; Sander van Boheemen; Theo M Bestebroer; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  N Engl J Med       Date:  2012-10-17       Impact factor: 91.245

6.  Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction.

Authors:  V M Corman; I Eckerle; T Bleicker; A Zaki; O Landt; M Eschbach-Bludau; S van Boheemen; R Gopal; M Ballhause; T M Bestebroer; D Muth; M A Müller; J F Drexler; M Zambon; A D Osterhaus; R M Fouchier; C Drosten
Journal:  Euro Surveill       Date:  2012-09-27

7.  Identification of a severe acute respiratory syndrome coronavirus-like virus in a leaf-nosed bat in Nigeria.

Authors:  Phenix-Lan Quan; Cadhla Firth; Craig Street; Jose A Henriquez; Alexandra Petrosov; Alla Tashmukhamedova; Stephen K Hutchison; Michael Egholm; Modupe O V Osinubi; Michael Niezgoda; Albert B Ogunkoya; Thomas Briese; Charles E Rupprecht; W Ian Lipkin
Journal:  mBio       Date:  2010-10-12       Impact factor: 7.867

8.  Bat coronaviruses and experimental infection of bats, the Philippines.

Authors:  Shumpei Watanabe; Joseph S Masangkay; Noriyo Nagata; Shigeru Morikawa; Tetsuya Mizutani; Shuetsu Fukushi; Phillip Alviola; Tsutomu Omatsu; Naoya Ueda; Koichiro Iha; Satoshi Taniguchi; Hikaru Fujii; Shumpei Tsuda; Maiko Endoh; Kentaro Kato; Yukinobu Tohya; Shigeru Kyuwa; Yasuhiro Yoshikawa; Hiroomi Akashi
Journal:  Emerg Infect Dis       Date:  2010-08       Impact factor: 6.883

9.  Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa.

Authors:  Ndapewa Laudika Ithete; Samantha Stoffberg; Victor Max Corman; Veronika M Cottontail; Leigh Rosanne Richards; M Corrie Schoeman; Christian Drosten; Jan Felix Drexler; Wolfgang Preiser
Journal:  Emerg Infect Dis       Date:  2013-10       Impact factor: 6.883

10.  A randomized controlled trial of interventions to impede date palm sap contamination by bats to prevent nipah virus transmission in Bangladesh.

Authors:  Salah Uddin Khan; Emily S Gurley; M Jahangir Hossain; Nazmun Nahar; M A Yushuf Sharker; Stephen P Luby
Journal:  PLoS One       Date:  2012-08-08       Impact factor: 3.240

View more
  327 in total

1.  Middle East Respiratory Syndrome Coronavirus nsp1 Inhibits Host Gene Expression by Selectively Targeting mRNAs Transcribed in the Nucleus while Sparing mRNAs of Cytoplasmic Origin.

Authors:  Kumari G Lokugamage; Krishna Narayanan; Keisuke Nakagawa; Kaori Terasaki; Sydney I Ramirez; Chien-Te K Tseng; Shinji Makino
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

2.  Novel Alphacoronaviruses and Paramyxoviruses Cocirculate with Type 1 and Severe Acute Respiratory System (SARS)-Related Betacoronaviruses in Synanthropic Bats of Luxembourg.

Authors:  Maude Pauly; Jacques B Pir; Catherine Loesch; Aurélie Sausy; Chantal J Snoeck; Judith M Hübschen; Claude P Muller
Journal:  Appl Environ Microbiol       Date:  2017-08-31       Impact factor: 4.792

3.  Progress stalled on coronavirus.

Authors:  Declan Butler
Journal:  Nature       Date:  2013-09-19       Impact factor: 49.962

4.  Medical School Hotline: Pacific Center for Emerging Infectious Diseases Research.

Authors:  Richard Yanagihara; Vivek R Nerurkar; George Hui; Gwen A Jacobs
Journal:  Hawaii J Med Public Health       Date:  2017-01

5.  Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection.

Authors:  Julie Dyall; Christopher M Coleman; Brit J Hart; Thiagarajan Venkataraman; Michael R Holbrook; Jason Kindrachuk; Reed F Johnson; Gene G Olinger; Peter B Jahrling; Monique Laidlaw; Lisa M Johansen; Calli M Lear-Rooney; Pamela J Glass; Lisa E Hensley; Matthew B Frieman
Journal:  Antimicrob Agents Chemother       Date:  2014-05-19       Impact factor: 5.191

6.  Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture.

Authors:  Adriaan H de Wilde; Dirk Jochmans; Clara C Posthuma; Jessika C Zevenhoven-Dobbe; Stefan van Nieuwkoop; Theo M Bestebroer; Bernadette G van den Hoogen; Johan Neyts; Eric J Snijder
Journal:  Antimicrob Agents Chemother       Date:  2014-05-19       Impact factor: 5.191

7.  Recognition of the murine coronavirus genomic RNA packaging signal depends on the second RNA-binding domain of the nucleocapsid protein.

Authors:  Lili Kuo; Cheri A Koetzner; Kelley R Hurst; Paul S Masters
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

8.  Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution.

Authors:  Xian-Chun Tang; Sudhakar S Agnihothram; Yongjun Jiao; Jeremy Stanhope; Rachel L Graham; Eric C Peterson; Yuval Avnir; Aimee St Clair Tallarico; Jared Sheehan; Quan Zhu; Ralph S Baric; Wayne A Marasco
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

9.  Middle east respiratory syndrome coronavirus 4a protein is a double-stranded RNA-binding protein that suppresses PACT-induced activation of RIG-I and MDA5 in the innate antiviral response.

Authors:  Kam-Leung Siu; Man Lung Yeung; Kin-Hang Kok; Kit-San Yuen; Chun Kew; Pak-Yin Lui; Chi-Ping Chan; Herman Tse; Patrick C Y Woo; Kwok-Yung Yuen; Dong-Yan Jin
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

10.  Receptor variation and susceptibility to Middle East respiratory syndrome coronavirus infection.

Authors:  Arlene Barlan; Jincun Zhao; Mayukh K Sarkar; Kun Li; Paul B McCray; Stanley Perlman; Tom Gallagher
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.